| Steven M Pitschka, MD | |
|
115 10th Ave Ne, Essentia Health Deer River, Deer River, MN 56636-8795 | |
| (218) 246-2900 | |
| Not Available |
| Full Name | Steven M Pitschka |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 115 10th Ave Ne, Deer River, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457329138 | NPI | - | NPPES |
| 080013301 | Other | MN | MEDICARE WPS - HOSPITAL |
| 677957300 | Medicaid | MN | |
| 080015007 | Other | MN | MEDICARE WPS - MCGREGOR C |
| 080015008 | Other | MN | MEDICARE WPS - AITKIN CLI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 39852 (Minnesota) | Primary |
| Entity Name | Pine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326041633 PECOS PAC ID: 3870406945 Enrollment ID: O20031106000272 |
News Archive
Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.
Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
Neptune Technologies & Bioressources Inc. and Acasti Pharma, a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares on the TSX Venture Exchange under the ticker symbol APO.
As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease.
› Verified 6 days ago
| Entity Name | St Marys Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457393035 PECOS PAC ID: 6901706357 Enrollment ID: O20040112000118 |
News Archive
Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.
Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
Neptune Technologies & Bioressources Inc. and Acasti Pharma, a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares on the TSX Venture Exchange under the ticker symbol APO.
As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease.
› Verified 6 days ago
| Entity Name | Deer River Healthcare Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225049018 PECOS PAC ID: 1850388448 Enrollment ID: O20040427000428 |
News Archive
Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.
Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
Neptune Technologies & Bioressources Inc. and Acasti Pharma, a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares on the TSX Venture Exchange under the ticker symbol APO.
As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease.
› Verified 6 days ago
| Entity Name | Northern Pines Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639278609 PECOS PAC ID: 3870565641 Enrollment ID: O20040811000988 |
News Archive
Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.
Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
Neptune Technologies & Bioressources Inc. and Acasti Pharma, a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares on the TSX Venture Exchange under the ticker symbol APO.
As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease.
› Verified 6 days ago
| Entity Name | Essentia Health Moose Lake |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1154959880 PECOS PAC ID: 6608290333 Enrollment ID: O20200728000758 |
News Archive
Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.
Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
Neptune Technologies & Bioressources Inc. and Acasti Pharma, a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares on the TSX Venture Exchange under the ticker symbol APO.
As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease.
› Verified 6 days ago
| Entity Name | Essentia Health Moose Lake |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154959880 PECOS PAC ID: 6608290333 Enrollment ID: O20200730001548 |
News Archive
Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.
Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
Neptune Technologies & Bioressources Inc. and Acasti Pharma, a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares on the TSX Venture Exchange under the ticker symbol APO.
As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven M Pitschka, MD 115 10th Ave Ne, Essentia Health Deer River, Deer River, MN 56636-8795 Ph: (218) 246-2900 | Steven M Pitschka, MD 115 10th Ave Ne, Essentia Health Deer River, Deer River, MN 56636-8795 Ph: (218) 246-2900 |
News Archive
Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.
Men who undergo radiation for prostate cancer have nearly double the risk of developing rectal cancer when compared to men who opt to have surgery to treat prostate cancer, according to a study published today in the American Gastroenterological Association (AGA) journal Gastroenterology.
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
Neptune Technologies & Bioressources Inc. and Acasti Pharma, a Neptune subsidiary, announces that Acasti has received conditional approval for the listing of its class A common shares on the TSX Venture Exchange under the ticker symbol APO.
As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease.
› Verified 6 days ago